Shanghai Medicilon Inc. (Medicilon) has recently won the "Best Partner Award" from Gluetacs Therapeutics and the "2003 Best Partner Award" from SicaGene. On January 29, Medicilon was awarded the 2023 "Best Strategic Partner" award by NewDEL Biotech. Trust makes each other successful, Collaboration creates the future NewDEL Biotech is the first biopharmaceutical company incubated by the Guangdong Small Molecule New Drug Innovation Center (Small Molecule Center). Relying on the independently developed "SmartDEL technology platform" and unique living cell screening technology, a full life cycle system for innovative drugs focusing on the design, development and industrialization of FIC innovative drugs has been established to target unmet clinical needs. In addition, dozens of R&D pipelines have been laid out. It can be said that "innovation" has become the foundation and confidence for the development of NewDEL Biology. Like NewD...
Integrated Drug Discovery Services- Chemistry, Biology & Preclinical Services